Latest News and Press Releases

PORTLAND, OR--(Marketwired - Nov 6, 2013) - MolecularMD Corp., a molecular diagnostics company focused on providing the highest quality companion diagnostics and clinical trials support services to...

PORTLAND, OR--(Marketwired - Oct 17, 2013) - MolecularMD Corp., a molecular diagnostics company focused on providing the highest quality companion diagnostics and clinical trials support services to...

PORTLAND, OR--(Marketwired - Aug 8, 2013) - MolecularMD Corporation today announced that Dr. Glenn Miller has been appointed to the executive management team as Chief Technology Officer and...

PORTLAND, OR--(Marketwired - Jul 29, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...

PORTLAND, OR--(Marketwired - May 30, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...

PORTLAND, OR--(Marketwired - Apr 9, 2013) - MolecularMD Corp. announced today that it has developed and clinically validated assays for determining LKB1 mutation and expression status in patient...

PORTLAND, OR--(Marketwired - Apr 4, 2013) - Today MolecularMD Corp. announced the launch of its next generation sequencing (NGS) services designed to support MolecularMD's pharmaceutical and...

PORTLAND, OR--(Marketwire - Jan 28, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...

PORTLAND, OR--(Marketwire - Dec 6, 2012) - MolecularMD, based in Portland, OR, has formed a collaborative research agreement with Ventana Medical Systems, Inc. (Ventana), a member of the Roche...

PORTLAND, OR--(Marketwire - Dec 6, 2012) - MolecularMD Corp. announced today that it will present data at the annual meeting of the American Society of Hematology conference, pertaining to the...